Greenstone LLC

AUGUST 25, 2016

Greenstone LLC offers a robust, diverse, and extensive portfolio of generic medications, covering a broad range of therapeutic areas.

Greenstone’s portfolio includes authorized generics that are generally made and sold under the new drug application (NDA) of the brand-name drug. This means they have the same efficacy and safety profiles, and contain the same active and inactive ingredients as the brand-name drug. Greenstone-authorized generics are typically the same size, shape, and color of the brand-name drug.

With a focus on understanding the customers’ structures, goals, and needs, Greenstone makes it a goal to provide trust, ongoing partnership, and service excellence. Greenstone is committed to delivering reliable generic medications along with quality and value to its customers.

Greenstone is dedicated to maintaining a dependable supply of generic medicines. As a subsidiary of Pfizer, one of the world’s premier biopharmaceutical companies, Greenstone holds itself to the same high industry standards, demonstrating a commitment to excellence in manufacturing and supply—from the procurement of raw materials to product delivery. Through US retail generic sales, Greenstone aims to maximize value to Pfizer shareholders and stakeholders.

Looking forward, Greenstone will continue to strive for sustainable growth, while adapting to the ever-changing retail generics business. Greenstone’s core values—trust, transparency, communication, customer service, and integrity—will continue to drive every aspect of the Greenstone experience.

For more information, visit